Seaton Max E, Parent Brodie A, Sood Ravi F, Wurfel Mark M, Muffley Lara A, O'Keefe Grant E, Gibran Nicole S
*Harborview Department of Surgery, University of Washington Medical Center, Seattle, Washington†Department of Surgery, University of Maryland Medical Center, Baltimore, Maryland‡Harborview Department of Medicine, University of Washington Medical Center, Seattle, Washington.
Shock. 2017 Jan;47(1):79-85. doi: 10.1097/SHK.0000000000000708.
The aim of the study was to determine if melanocortin-1 receptor (MC1R) single nucleotide polymorphisms (SNPs) are associated with complicated sepsis after trauma.
Nosocomial infections are an important cause of morbidity and mortality after trauma. Several SNPs in inflammation-related genes have been associated with sepsis. MC1R is an anti-inflammatory mediator that may be involved in the immune response after trauma.
We genotyped eight common MC1R SNPs in genomic DNA from subjects enrolled in a previously reported prospective cohort study. Subjects were adult trauma patients admitted to the intensive care unit at a Level 1 trauma center (2003-2005).
A total of 1,246 subjects were included in the analysis. The majority were male (70%), severely injured (81%), and injured by a blunt mechanism (89%). Forty percent developed sepsis, and 23% developed complicated sepsis, which was defined as sepsis with organ dysfunction. In logistic regression analysis, with adjustments for age, sex, body mass index, injury severity score, red blood cell transfusion requirement, and mechanism of injury, the MC1RR163Q variant (rs885479) was associated with a lower risk of developing complicated sepsis (adjusted odds ratio [ORadj] = 0.48, 95% confidence interval [CI]: 0.28-0.81, P = 0.006). In a subgroup of 511 subjects with genome-wide SNP data, the association between the MC1RR163Q variant and complicated sepsis remained significant after adjusting for genetic substructure (by principal components) and the above clinical factors (ORadj = 0.30, 95% CI: 0.13-0.70, P = 0.005).
MC1RR163Q is associated with a lower risk of complicated sepsis after trauma. Therapeutic targeting of MC1R may be beneficial for trauma patients at risk for complicated sepsis.
本研究旨在确定黑素皮质素-1受体(MC1R)单核苷酸多态性(SNP)是否与创伤后复杂性脓毒症相关。
医院感染是创伤后发病和死亡的重要原因。炎症相关基因中的几个SNP与脓毒症有关。MC1R是一种抗炎介质,可能参与创伤后的免疫反应。
我们对参与先前报道的前瞻性队列研究的受试者基因组DNA中的8个常见MC1R SNP进行了基因分型。受试者为入住一级创伤中心重症监护病房的成年创伤患者(2003 - 2005年)。
共有1246名受试者纳入分析。大多数为男性(70%),重伤(81%),钝性机制损伤(89%)。40%发生脓毒症,23%发生复杂性脓毒症,复杂性脓毒症定义为伴有器官功能障碍的脓毒症。在逻辑回归分析中,经年龄、性别、体重指数、损伤严重程度评分、红细胞输注需求和损伤机制校正后,MC1R R163Q变异体(rs885479)与发生复杂性脓毒症的风险较低相关(校正比值比[ORadj] = 0.48,95%置信区间[CI]:0.28 - 0.81,P = 0.006)。在一个有全基因组SNP数据的511名受试者亚组中,经遗传亚结构(通过主成分)和上述临床因素校正后,MC1R R163Q变异体与复杂性脓毒症之间的关联仍然显著(ORadj = 0.30,95% CI:0.13 - 0.70,P = 0.005)。
MC1R R163Q与创伤后复杂性脓毒症风险较低相关。针对MC1R的治疗靶点可能对有发生复杂性脓毒症风险的创伤患者有益。